Table 2. Budget impact analysis,... | American Society of Hematology

Table 2.

Budget impact analysis, Medicaid perspective for United States and selected state programs

	Total no. eligible for gene therapy	No. eligible for therapy per 100 000 plan enrollees	No. to receive therapy, year 1	Budget impact, year 1 (million USD)	PMPM cost, year 1	% change in year 1 PMPM cost from original model∗ ⁶	PMPM cost, year 5
United States†	7742	8.5	542	$1241.0	$1.13	18%	$0.75
Alabama	338	29.2	24	$54.2	$3.90	49%	$2.60
Washington, DC	69	23.6	5	$11.0	$3.15	45%	$2.10
Florida	904	18.7	63	$144.9	$2.50	41%	$1.67
Georgia	720	29.3	50	$115.4	$3.92	57%	$2.61
Louisiana	445	23.7	31	$71.4	$3.17	46%	$2.11
Maryland	329	19.7	23	$52.8	$2.63	59%	$1.75
Mississippi	203	26.5	14	$32.5	$3.55	–4%	$2.36
North Carolina	409	18.1	29	$65.5	$2.41	28%	$1.60
South Carolina	350	27.1	25	$56.1	$3.62	43%	$2.42
Virginia	339	17.2	24	$54.4	$2.30	20%	$1.54
Sample average	411	21.9	29	$65.8	$3.11	40%	$2.08

	Total no. eligible for gene therapy	No. eligible for therapy per 100 000 plan enrollees	No. to receive therapy, year 1	Budget impact, year 1 (million USD)	PMPM cost, year 1	% change in year 1 PMPM cost from original model∗ ⁶	PMPM cost, year 5
United States†	7742	8.5	542	$1241.0	$1.13	18%	$0.75
Alabama	338	29.2	24	$54.2	$3.90	49%	$2.60
Washington, DC	69	23.6	5	$11.0	$3.15	45%	$2.10
Florida	904	18.7	63	$144.9	$2.50	41%	$1.67
Georgia	720	29.3	50	$115.4	$3.92	57%	$2.61
Louisiana	445	23.7	31	$71.4	$3.17	46%	$2.11
Maryland	329	19.7	23	$52.8	$2.63	59%	$1.75
Mississippi	203	26.5	14	$32.5	$3.55	–4%	$2.36
North Carolina	409	18.1	29	$65.5	$2.41	28%	$1.60
South Carolina	350	27.1	25	$56.1	$3.62	43%	$2.42
Virginia	339	17.2	24	$54.4	$2.30	20%	$1.54
Sample average	411	21.9	29	$65.8	$3.11	40%	$2.08

USD, US dollar.

Percent change in the year 1 PMPM impact when comparing the original model with the current and updated results.⁶

The United States indicates all state Medicaid plans in aggregate.